110 results about "Glucose meter device" patented technology

A glucose measuring system includes a glucose meter that incorporates wireless communication capabilities. The meter can advantageously be a low cost meter by eliminating expensive components, such as the display. The user nevertheless is able to retrieve and view his or her glucose values by referring to displays within the glucose measuring local area network. Feedback via these displays can advantageously be used by the diabetic to create a higher level of confidence and safety.

A test apparatus having a base which performs a plurality of tests for different analytes in body fluids. A portable tester, such as a glucose meter, is detachably mounted to the base and provides a convenient and ergonomic hand-held instrument which a diabetic may carry to frequently monitor blood glucose levels. When mounted or docked to the base, the portable tester is data linked to the base. The invention provides a communications network among the base, the portable tester and another device such as a PC. The portable tester can therefore be kept small and inexpensive since advanced computing and data storage capabilities are provided in the base or a PC.

A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.

Described and illustrated herein is an exemplary method of operating an analyte measurement device having a display, user interface, processor, memory, and user interface buttons. Such method can be achieved by measuring an analyte with the analyte measurement device, displaying a value representative of the analyte, querying a user to select a predetermined flag to associate the predetermined flag with the value, and pressing only one of the user interface buttons once to store the predetermined flag with the value in the memory of the analyte measurement device. In one embodiment, the testing device is a glucose meter and the analyte being tested is glucose.

The present invention provides a multifunction health device, which comprises a meter and a platform. The meter has two electrodes arranged separately at its two sides or both arranged at its one side, and the meter has another electrode arranged in its bottom. The platform has four electrodes arranged in its top face, and a pressure sensor arranged in its inside. With or without some parts assisting, the single use of the meter can function as an ECG detector, a TENS machine, a thermometer, and a first sphygmomanometer. Connecting with the platform, the meter and the platform can function as an ECG detector, a weight scale, and a body composition estimator. Further, the meter can alternatively connect with a chassis thus functioning as a second sphygmomanometer, a stethoscope, a glucose meter, or a pulse oximeter.

A portable combination for measuring a glucose concentration value in a sample has a portable glucose meter (GM) having a test strip port for receiving a disposable electrochemical test strip, means for calculating a glucose concentration value in a sample applied to a test strip received in the test strip port, and optionally a rechargeable GM battery. Next the combination has a portable rechargeable supplemental battery pack (SBP). The combination also has a web enabled portable device (WEPD) having a rechargeable WEPD battery and a wireless connection to the internet. The GM, the SBP, and the WEPD are electrically coupled to allow power transfer between the GM, the SBP, and the WEPD. The GM and the WEPD are communicatively coupled to allow for data transfer between the GM and the WEPD. The GM and SBP are detachable from and reattachable to the WEPD to form the portable combination. Lastly the combination has means for managing battery operations of the combination. These means are effective to cause the GM to draw operating power first from the SBP, second from the WEPD battery, and third from the GM battery, if the GM battery is present.

An apparatus for measuring a concentration of a substance in an eye (13) includes a measurement light source (4) producing a measurement light beam having a first wavelength at which the substance has a non-zero first absorption coefficient. The apparatus further includes a reference light source (6) producing a reference light beam having a second wavelength at which the substance has a second absorption coefficient which is substantially equal to zero. At least a portion of the measurement light beam retro-reflects from the retina (17) and at least a portion of the reference light beam retro-reflects from the retina (17). The apparatus further includes a detector (9) responsive to light having the first wavelength by generating a measurement signal and responsive to light having the second wavelength by generating a reference signal.

A disposable glucometer is disclosed which includes a testing region for receiving a test strip and electronic components to perform blood glucose monitoring, a cell phone interface for relaying test results to a monitoring station or server (which can be through a Bluetooth radio), and a multi-strip test strip holder. The glucometer includes a mechanism to automatically load test strips, one at a time, from the multi-strip test strip holder into the testing region, and a mechanism to eject the strip from the testing region after the test is complete. The test strip holder is preferably encased in a transparent material or otherwise includes a visual indicator so that the number of strips remaining strips and available for testing can be determined. In one embodiment, the entire unit is disposable, and is discarded when all of the strips have been used. In another embodiment, the test strip holder portion of the unit is removed and replaced with a new test strip holder which is loaded with test strips.

A general methodology for the development of highly sensitive and selective sensors that can achieve portable, low-cost and quantitative detection of a broad range of targets using only a personal glucose meter (PGM) is disclosed. The method uses recognition molecules that are specific for a target agent, enzymes that can convert an enzyme substrate into glucose, and PGM. Also provided are sensors, which can include a solid support to which is attached a recognition molecule that permits detection of a target agent, wherein the recognition molecule specifically binds to the target agent in the presence of the target agent but not significantly to other agents as well as an enzyme that can catalyze the conversion of a substance into glucose, wherein the enzyme is attached directly or indirectly to the recognition molecule, and wherein in the presence of the target agent the enzyme can convert the substance into glucose. The disclosed sensors can be part of a lateral flow device. Methods of using such sensors for detecting target agents are also provided.

The present invention provides a multifunction health device, which comprises a meter and a platform. The meter has two electrodes arranged separately at its two sides, and another electrode arranged in its bottom. The platform has four electrodes arranged in its top face, and a pressure sensor arranged in its inside. With or without some parts assisting, the single use of the meter can function as an ECG detector, a TENS machine, a thermometer, and a first sphygmomanometer. Connecting with the platform, the meter and the platform can function as an ECG detector, a weight scale, and a body composition estimator. Further, the meter can alternatively connect with a chassis thus functioning as a second sphygmomanometer, a stethoscope, a glucose meter, or a pulse oximeter.

A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large amount of blood glucose concentration measurements and other physiological parameters related to the glycemia of a patient. In particular, a method of monitoring glycemia in a patient may include storing a patient's data on a suitable device, such as, for example, a glucose meter. The patient's data may include blood glucose concentration measurements. The diabetes management system or process may be installed on, but is not limited to, a personal computer, an insulin pen, an insulin pump, or a glucose meter. The diabetes management system or process may identify a plurality of pattern types from the data including a testing / dosing pattern, a hypoglycemic pattern, a hyperglycemic pattern, a variability pattern, and a comparative pattern. After identifying a particular pattern with the data management system or process, a warning message may be displayed on a screen of a personal computer or a glucose meter. Other messages can also be provided to ensure compliance of any prescribed diabetes regiments or to guide the patient in managing the patient's diabetes.

A glucose meter module integrated into a holster device that can securely accommodate another device such as a portable server device or an insulin pump is described. The glucose measuring module and the health device communicate with each other by a short range wireless modality. In the case in which the accommodated device is a server, such as personal digital assistant or cell phone, the device stores data in a memory, displays data on a visual display, and can wirelessly transmit such data to other devices within a personal area network. In the case where the accommodated device is a cell phone, the phone can further transmit data to remote sites. In the case where the accommodated device is an insulin pump, wirelessly received data are stored in a memory, are available for visual display on the insulin pump, and can be incorporated into the electronic processes that regulate the performance of the pump.

A sensor for optically measuring an analyte contained in a liquid biological sample, particularly measuring the glucose content of blood in a glucose meter. The sensor in a preferred embodiment takes the form of a snow-boot. That is, it has a top portion including an air vent and an area that the user grasps to insert and remove the sensor from the slot in a glucose meter. The bottom or toe region of the sensor extends from the glucose meter and provides the entrance to a capillary channel for introducing a sample of blood into the meter, where it contacts reagents providing an optical response. The optics within the meter read the optical response of the reagents and correlates it with the glucose content of the sample.

The invention discloses a wearable noninvasive dynamic blood glucose monitor based on photo-acoustic spectrometry features and relates to the field of blood glucose level detection in order to solve the technical problems that an existing noninvasive glucometer is single in detection structure, necessary measurement compensation and correction lack, work precision of the existing noninvasive glucometer is greatly affected by the environment when there is individual difference, and the deviation between a real blood glucose value and a measured value is large. Besides, the existing glucometer has the technical problems of being inconvenient to carry, low in stability, poor in universality and the like. The wearable noninvasive dynamic blood glucose monitor mainly structurally comprises a multi-wavelength tunable fiber laser, a microprocessor, a display module, an impedance testing unit, a temperature sensor, a photoacoustic cavity, an optical substrate and transparent colloid. The blood glucose monitor is used for improving detection precision, can also be used for detecting impedance, temperature and other signals, corrects data, and avoids influences of the surrounding environment.

The present invention is a method of preventing reuse of test strips for measuring an analyte or indicator such as glucose in a physiological fluid such as blood, interstitial fluid, or urine. The present invention also relates to a method of preventing reuse of test strips incorporating an integrated lance such as a needle, blade, or other sharp or skin puncturing device. Certain types of medical devices such as, for example, glucose test strips were intended to be tested only once and then disposed. This requirement is often needed because the reagent chemistry in many test strips is not suitable for measuring glucose a second time. However, it is possible that some user will accidentally test a previously used test strip. This could potentially become a problem if the glucose meter attempts to make a glucose measurement and outputs a result. Therefore, it is desirable that a single use test strip and meter have a prescribed method for preventing a previously tested test strip from being reused.

The invention provides a one-step type integrated blood glucose meter comprising a blood glucose meter body, a detecting box in an accommodating groove of the blood glucose meter body and a glycosylated hemoglobin detecting unit. The blood glucose meter body is provided with a control circuit. The detecting box is provided with a blood glucose detecting unit corresponding to a blood collecting port and a guide structure allowing the blood glucose detecting unit provided with a blood collecting needle and a blood glucose test strip to collect blood movably. The blood glucose meter body is provided with a drive mechanism connected to the control circuit, and the drive mechanism is used for driving the blood glucose detecting unit to move by sensitive triggering to allow the blood colleting needle to penetrate the blood collecting port to collect blood and return. A glycosylated hemoglobin detecting position is formed on the surface of the blood glucose meter body through the glycosylated hemoglobin detecting unit. The blood glucose meter body further integrally corresponds to a wireless receiving unit, connected to a wireless emitting unit of a blood glucose sensor planted subcutaneously, and a glucose interpreting unit which is connected to the wireless receiving unit and which is used for dynamically converting and displaying blood glucose values. The blood glucose meter integrates functions of blood glucose detection, dynamic blood glucose monitoring and glycosylated hemoglobin detection, and is small in size and convenient to operate.

Various embodiments that allow for improved accuracy in the measurement of glucose with a glucose meter and a biosensor, principally, by using pulsed signal inputs to the biosensor and selecting at least one specific pulsed output from the biosensor to determine a glucose concentration that is less affected by interfering chemical substances that might be present in the fluid sample.

Methods are provided for correcting an analyte concentration measurement that may be influenced by hematocrit (HCT), especially a glucose concentration measurement. The methods include determining by means of a reference instrument a HCT reference value of a reference blood sample taken from a specific user, applying a fresh blood sample of the user on a disposable analytical test element, measuring the glucose value of the fresh blood sample by single use of the test element in a glucose meter, determining a HCT correction value using at least the HCT reference value, and adjusting the measured glucose value using the HCT correction value to receive an adjusted glucose value. Also provided are devices and system incorporating or for performing the methods.

The invention discloses a blood glucose monitoring device based on a smart phone, and a realization method thereof. The blood glucose monitoring device is characterized in that the smart phone blood instrument comprises three main hardware systems which are a blood glucose test strip module, a blood glucose signal acquisition module, and a smart phone. According to the invention, the blood glucose monitoring device is combined with the smart phone. The blood glucose monitoring device has the advantages of small volume, convenient carrying, low cost, stable performance, and simple and reliable operation. Also, blood glucose data can be recorded for a long time, such that user and physicians can conveniently tracking blood glucose history and trends. With the monitoring device system provided by the invention, a user can also conveniently order blood glucose test strips.

The invention discloses a detachable glucometer capable of automatically sampling and testing blood. The detachable glucometer comprises a glucometer body provided with a mounting groove; a blood sampler is inserted in the mounting groove, and blood sampling can be completed by putting a finger into a sampling groove. The glucometer body is also provided with a storage groove; two test paper reelson the storage groove are connected with test paper through transmission structures such as a first transmission wheel, a second transmission wheel, and a test chamber; the part, between the first transmission wheel and the second transmission wheel, of the test paper runs through the sampling groove; after blood sampling, people pull out the finger, sampled blood is applied to the test paper, the test paper with the sampled blood is transferred to the test chamber through a friction force, and then the sampled blood is tested in the test chamber; since blood sampling and blood testing are carried out simultaneously, processes and time for blood glucose testing are both saved. The side wall of the storage groove is provided with a transparent cover plate which is a detachable structure, usage of the test paper can be observed and new test paper can be changed rapidly if the test paper is used up.

The invention relates to a method for detecting a transcription factor by a biosensor and a glucometer. The method comprises the following steps of 1, fixing a nucleic acid sequence specifically binding to a transcription factor on a solid matrix, and adding a sample into the solid matrix with the nucleic acid sequence to obtain a compound, 2, fixing a transcription factor antibody and invertase on carriers, 3, mixing the solid matrix obtained by the step 1 and the carriers obtained by the step 2, and removing the unbound carriers, and 4, adding excess cane sugar into the mixture obtained by the step 3, carrying out a reaction for a certain time, detecting glucose content by a conventional glucometer, and converting the glucose content into content of the transcription factor in the sample. The method has high sensitivity and singularity, simple processes, a low cost and a fast detection rate, adopts the portable detection apparatuses, and is suitable for popular popularization.

The invention discloses a double-wavelength differential near-infrared non-invasive glucose meter. The double-wavelength differential near-infrared non-invasive glucose meter comprises a laser device I (11), a plane mirror I (12), a protective layer (13), a sample (14), a function generator (15), a laser device II (16), an optical neutral density light filter (17), a parabolic mirror I (18), a plane mirror II (19), a phase-locked amplifier (110), a broadband optical near-infrared detector (111), a double-channel optical filter (112) and a parabolic mirror II (113), wherein the optical neutral density light filter can be used for adjusting the power of the laser device II (16), so that the output power ratio of the laser device I (11) to the laser device II (16) is adjusted; and the phase difference is controlled by the function generator (15) and the phase-locked amplifier (110). The double-wavelength differential near-infrared non-invasive glucose meter not only has non-invasive detecting capacity, but also has high measuring precision, especially within a hypoglycemic range by combining the amplitude and the phase characteristics of the near-infrared light and utilizing the crest and trough variation difference of absorption spectrum. Meanwhile, the protective layer is provided for preventing the laser devices from accidently injuring skin tissues.

An apparatus and method for measuring a concentration of a substance in an eye using a retro-reflected measurement light beam having a first wavelength at which the substance has a non-zero first absorption coefficient and a retro-reflected reference light beam having a second wavelength at which the substance has a second absorption coefficient which is substantially equal to zero. The apparatus further includes a detector positionable to receive the retro-reflected measurement light beam and the retro-reflected reference light beam. The detector is responsive to light having the first wavelength by generating a measurement signal and responsive to light having the second wavelength by generating a reference signal. The apparatus further includes an electrical circuit coupled to the detector. The electrical circuit is responsive to the measurement signal and the reference signal to measure the concentration of the substance in the eye.

The invention relates to a noninvasive glucometer. An injection platform comprises insulin automatic injection equipment, blood oxygen saturation detection equipment, noninvasive blood sugar detection equipment and a DSP (digital signal processing) processing chip, wherein the blood oxygen saturation detection equipment and the noninvasive blood sugar detection equipment are used for extracting blood oxygen saturation data and blood sugar data of a tested person respectively; the DSP processing chip is connected with the insulin automatic injection equipment, the blood oxygen saturation detection equipment and the noninvasive blood sugar detection equipment respectively; and a blood oxygen supply state of the tested person is determined on the basis of the blood oxygen saturation data, and injection parameters of the insulin automatic injection equipment are determined on the basis of the blood sugar data. By virtue of the noninvasive glucometer provided by the invention, on the one hand, the blood oxygen supply condition of the tested person can be detected automatically, and on the other hand, adaptive injection control of insulin can be realized.

The invention relates to a laser Raman technique-based glucometer and relates to the field of medical detecting instruments, biological medical detection and health monitoring. The laser Raman technique-based glucometer comprises a power source, a laser source, a Raman spectral signal acquisition module, a signal processing circuit, a master control chip and a data analysis and display system. Molecular vibration and rotation structural information is obtained by the analysis on Raman scattering generated by mutual action of specific-wavelength laser and a measured object and the analysis by Raman spectral analysis technique, so that qualitative and quantitative analysis is quick, simple, repeatable and lossless. Raman spectrum of glucose molecules is well specific, fundamental frequency spectral lines are clear, and recognition is easy. Raman spectrum is non-sensitive to polar materials such as water, and interference by Raman spectrum of the water in near-infrared areas is avoided effectively. Samples need not be pretreated, and in-situ measurement is available.